KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Alnylam Pharmaceuticals (ALNY) Inventory Average (2018 - 2025)

Historic Inventory Average for Alnylam Pharmaceuticals (ALNY) over the last 8 years, with Q3 2025 value amounting to $73.5 million.

  • Alnylam Pharmaceuticals' Inventory Average fell 806.22% to $73.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $73.5 million, marking a year-over-year decrease of 806.22%. This contributed to the annual value of $83.8 million for FY2024, which is 2313.21% down from last year.
  • Per Alnylam Pharmaceuticals' latest filing, its Inventory Average stood at $73.5 million for Q3 2025, which was down 806.22% from $68.6 million recorded in Q2 2025.
  • Alnylam Pharmaceuticals' Inventory Average's 5-year high stood at $130.4 million during Q1 2023, with a 5-year trough of $68.6 million in Q2 2025.
  • For the 5-year period, Alnylam Pharmaceuticals' Inventory Average averaged around $90.4 million, with its median value being $89.0 million (2024).
  • Per our database at Business Quant, Alnylam Pharmaceuticals' Inventory Average surged by 5820.15% in 2023 and then tumbled by 2979.09% in 2024.
  • Alnylam Pharmaceuticals' Inventory Average (Quarter) stood at $92.1 million in 2021, then soared by 32.66% to $122.2 million in 2022, then decreased by 24.35% to $92.5 million in 2023, then dropped by 16.45% to $77.2 million in 2024, then decreased by 4.81% to $73.5 million in 2025.
  • Its last three reported values are $73.5 million in Q3 2025, $68.6 million for Q2 2025, and $72.0 million during Q1 2025.